Press "Enter" to skip to content

The content provided here is for informational and educational purposes only and does not constitute investment advice, a recommendation, an offer or solicitation to buy or sell any financial instrument, security, cryptocurrency, or investment product. Nothing in this material should be construed as personalized financial, tax, legal, or other professional advice tailored to your individual circumstances. Prior to making any investment or financial decisions you should consult with a qualified financial adviser, tax professional, or other relevant expert who can take into account your specific objectives and circumstances.

Markets are inherently uncertain and past performance is not indicative of future results. Prices can move quickly and unpredictably due to a wide range of factors, including economic data, monetary policy decisions, geopolitical events, regulatory changes, issuer-specific news, liquidity conditions, and technological developments. Cryptocurrencies and other digital assets in particular are subject to extreme volatility, rapid regulatory shifts, cyber security risks, and the potential for total loss. Do not invest funds you cannot afford to lose.

Home » VANGUARD

Posts tagged as “VANGUARD”

Moderna Soars 127% on Melanoma Therapy Win $MRNA

By Financier.News on August 19, 2026

Moderna Soars 127% on Melanoma Therapy Win $MRNA

Moderna more than Doubles on Late-Stage Melanoma Data Moderna (MRNA) shares surged 127.13% to $143.00 by noon EDT on Wednesday, August 19, 2026, after the…

Inflation Cools, Nvidia’s $500B AI Debt Plan $NVDA

By Financier.News on August 13, 2026

Inflation Cools, Nvidia’s $500B AI Debt Plan $NVDA

Wholesale Inflation Cools, Fed Rate Cut Bets Rise US producer prices rose less than expected in July, with the core PPI gaining 0.2% month-over-month versus…